[go: up one dir, main page]

NO930390D0 - Nye hetaryloxy-beta-carboliner, deres fremstilling og anvendelse i legemidler - Google Patents

Nye hetaryloxy-beta-carboliner, deres fremstilling og anvendelse i legemidler

Info

Publication number
NO930390D0
NO930390D0 NO1993930390A NO930390A NO930390D0 NO 930390 D0 NO930390 D0 NO 930390D0 NO 1993930390 A NO1993930390 A NO 1993930390A NO 930390 A NO930390 A NO 930390A NO 930390 D0 NO930390 D0 NO 930390D0
Authority
NO
Norway
Prior art keywords
hetaryloxy
pharmaceuticals
preparation
new
beta carbolines
Prior art date
Application number
NO1993930390A
Other languages
English (en)
Other versions
NO300771B1 (no
NO930390L (no
Inventor
Martin Krueger
Andreas Huth
Dieter Seidelmann
Herbert Schneider
Lechoslaw Turski
David Norman Stephens
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO930390L publication Critical patent/NO930390L/no
Publication of NO930390D0 publication Critical patent/NO930390D0/no
Publication of NO300771B1 publication Critical patent/NO300771B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO930390A 1991-06-05 1993-02-04 Nye hetaryloxy-<beta>-carboliner og deres anvendelse til fremstilling av legemidler NO300771B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4118741A DE4118741A1 (de) 1991-06-05 1991-06-05 Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
PCT/DE1992/000465 WO1992021679A1 (de) 1991-06-05 1992-06-04 NEUE HETARYLOXY-β-CARBOLINE, DEREN HERSTELLUNG UND VERWENDUNG IN ARZNEIMITTELN

Publications (3)

Publication Number Publication Date
NO930390L NO930390L (no) 1993-02-04
NO930390D0 true NO930390D0 (no) 1993-02-04
NO300771B1 NO300771B1 (no) 1997-07-21

Family

ID=6433410

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930390A NO300771B1 (no) 1991-06-05 1993-02-04 Nye hetaryloxy-<beta>-carboliner og deres anvendelse til fremstilling av legemidler

Country Status (21)

Country Link
US (2) US5348958A (no)
EP (1) EP0541757A1 (no)
JP (1) JPH06500341A (no)
KR (1) KR930701440A (no)
CN (1) CN1039906C (no)
AU (1) AU658631B2 (no)
CA (1) CA2087098A1 (no)
CZ (1) CZ281810B6 (no)
DE (1) DE4118741A1 (no)
FI (1) FI930293A0 (no)
HU (1) HUT63166A (no)
IE (1) IE921825A1 (no)
IL (1) IL102116A (no)
MX (1) MX9202616A (no)
NO (1) NO300771B1 (no)
NZ (1) NZ243014A (no)
PL (1) PL172481B1 (no)
PT (1) PT100565A (no)
RU (1) RU2105766C1 (no)
WO (1) WO1992021679A1 (no)
ZA (1) ZA924127B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
DE4308788A1 (de) * 1993-03-18 1994-09-22 Bayer Ag Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
DE4330175A1 (de) * 1993-08-31 1995-03-02 Schering Ag Alkoxy-substituierte beta-Carboline
AU761020B2 (en) * 1998-06-12 2003-05-29 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Beta-carboline compounds
GB0108337D0 (en) * 2001-04-03 2001-05-23 Novartis Ag Organic compounds
KR100808742B1 (ko) * 2004-03-11 2008-02-29 액테리온 파마슈티칼 리미티드 테트라하이드로피리도인돌 유도체
US9149465B2 (en) * 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8927551B2 (en) * 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8765735B2 (en) * 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
JP7512388B2 (ja) * 2019-11-27 2024-07-08 ワッカー ケミー アクチエンゲゼルシャフト クロロシラン混合物から不純物を除去する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
AU619203B2 (en) * 1987-08-28 1992-01-23 Schering Aktiengesellschaft Isoxazole-beta-carboline derivatives
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln

Also Published As

Publication number Publication date
JPH06500341A (ja) 1994-01-13
CN1069270A (zh) 1993-02-24
US5348958A (en) 1994-09-20
IL102116A (en) 1997-02-18
CZ396892A3 (en) 1993-10-13
KR930701440A (ko) 1993-06-11
PT100565A (pt) 1993-08-31
MX9202616A (es) 1993-09-01
AU1807492A (en) 1992-12-10
NO300771B1 (no) 1997-07-21
ZA924127B (en) 1993-02-24
FI930293A7 (fi) 1993-01-25
WO1992021679A1 (de) 1992-12-10
CN1039906C (zh) 1998-09-23
FI930293L (fi) 1993-01-25
PL172481B1 (pl) 1997-09-30
PL297839A1 (en) 1993-11-02
HUT63166A (en) 1993-07-28
NZ243014A (en) 1995-04-27
AU658631B2 (en) 1995-04-27
CZ281810B6 (cs) 1997-02-12
US5698555A (en) 1997-12-16
IL102116A0 (en) 1993-01-14
CA2087098A1 (en) 1992-12-06
EP0541757A1 (de) 1993-05-19
NO930390L (no) 1993-02-04
FI930293A0 (fi) 1993-01-25
HU9300595D0 (en) 1993-05-28
RU2105766C1 (ru) 1998-02-27
IE921825A1 (en) 1992-12-16
DE4118741A1 (de) 1992-12-10

Similar Documents

Publication Publication Date Title
NO933690D0 (no) Nye tiopyranopyrrolderivater og deres fremstilling
FI934220A7 (fi) Piperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
DK609489A (da) Imidazolderivater, deres fremstilling og anvendelse
NO303446B1 (no) Nye 2-sakkarinylmetylaryl- og -aryloksyacetater, preparater og anvendelse derav
DK633689A (da) Benzothiazolin-derivater, deres fresmtilling og anvendelse i laegemidler
NO930390L (no) Nye hetaryloxy-beta-carboliner, deres fremstilling og anvendelse i legemidler
FI932145A7 (fi) Uudet b-karboliinijohdannaiset, niiden valmistus ja käyttö lääkeaineis sa
DK633489D0 (da) Benzothiazolin-derivater, deres fremstilling og anvendelse i laegemidler
DK633789D0 (da) Benzothiazol-derivater, deres fremstilling og anvendelse i laegemidler
NO954763D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO884671D0 (no) Nye flourmetoksyfenyldihydropyridiner, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
DK3290A (da) Substituerede pyrido(2,3-d)pyrimidiner, deres fremstilling og anvendelse i laegemidler
DK489889D0 (da) Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler
NO902248D0 (no) Renininhiberende peptider, deres fremstilling og anvendelse i legemidler.
NO921908D0 (no) Aminosyreazetidinylsubstituerte pyridonderivater, deres fremstilling og anvendelse som medikamenter
NO982349D0 (no) Nye kinoksalindionderivater, deres fremstilling og anvendelse i legemidler
DK10487D0 (da) 4-aminoaryldihydropyridinlactoner, deres fremstilling og anvendelse i laegemidler
NO884672D0 (no) Nye fluormetoksyfenyl-dihydropyridiner, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
NO900275L (no) Benzopyranderivater, deres fremstilling og anvendelse i legemidler.
NO910721D0 (no) Diaminderivater og deres anvendelse i onkologi.
FI924167A7 (fi) Indolisulfonamidilla substituoidut dihydropyridiinit, menetelmä niidenvalmistamiseksi ja niiden käyttö lääkeaineissa
NO931511D0 (no) Nye beta-karbolinderivater, deres fremstilling og anvendelse i legemidler.
NO914653D0 (no) Substituerte dibenz-oksa-tiocinnoner, -12-oksyder og -12,12-dioksyder, deres fremstilling og anvendelse i legemidler
NO941666D0 (no) Nye lupanderivater, deres fremstilling og anvendelse i farmasöytiske preparater
NO913297D0 (no) Nye beta-karboliner, fremgangsmaate for deres fremstilling og anvendelse derav i legemidler.